Ensysce Biosciences (ENSC)
US Market

Ensysce Biosciences (ENSC) Stock Price & Analysis


ENSC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.28 - $220.66
Previous Close$2.32
Average Volume (3M)675.11K
Market Cap
Enterprise Value$1.26M
Total Cash (Recent Filing)$1.42M
Total Debt (Recent Filing)$19.12K
Price to Earnings (P/E)>-0.1
Aug 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-138.70
Shares Outstanding1,284,583
10 Day Avg. Volume43,750
30 Day Avg. Volume675,106
Standard Deviation0.34
Financial Highlights & Ratios
Price to Book (P/B)-2.28
Price to Sales (P/S)3.77
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.57
Enterprise Value/Gross Profit0.50
Enterprise Value/Ebitda-0.06
Price Target Upside557.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Ensysce Biosciences’s price range in the past 12 months?
Ensysce Biosciences lowest stock price was $2.28 and its highest was $220.66 in the past 12 months.
    What is Ensysce Biosciences’s market cap?
    Currently, no data Available
    When is Ensysce Biosciences’s upcoming earnings report date?
    Ensysce Biosciences’s upcoming earnings report date is Aug 14, 2023 which is in 65 days.
      How were Ensysce Biosciences’s earnings last quarter?
      Ensysce Biosciences released its earnings results on May 15, 2023. The company reported -$2.08 earnings per share for the quarter, beating the consensus estimate of -$5.077 by $2.997.
        Is Ensysce Biosciences overvalued?
        According to Wall Street analysts Ensysce Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Ensysce Biosciences pay dividends?
          Ensysce Biosciences does not currently pay dividends.
          What is Ensysce Biosciences’s EPS estimate?
          Ensysce Biosciences’s EPS estimate is -$2.77.
            How many shares outstanding does Ensysce Biosciences have?
            Ensysce Biosciences has 1,284,583 shares outstanding.
              What happened to Ensysce Biosciences’s price movement after its last earnings report?
              Ensysce Biosciences reported an EPS of -$2.08 in its last earnings report, beating expectations of -$5.077. Following the earnings report the stock price went down -3.571%.
                Which hedge fund is a major shareholder of Ensysce Biosciences?
                Currently, no hedge funds are holding shares in ENSC


                Ensysce Biosciences Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Ensysce Biosciences

                Leisure Acquisition Corp. operates as blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on the location-based leisure sector and leisure-related businesses. Leisure Acquisition was founded on September 11, 2017 and is headquartered in New York, NY.


                Top 5 ETFs holding ENSC

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold ENSC. The ETFs are listed according to market value of ENSC within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Corbus Pharmaceuticals
                Atara Biotherapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis